Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Am J Otolaryngol. 2020 Oct 22;42(1):102780. doi: 10.1016/j.amjoto.2020.102780

Table IV:

5-year Overall Survival in HPV-associated OPSCC adjusted for demographics, stage, tobacco, alcohol and SES

Addition of SES Variables*

Hazard Ratio 95% CI P-Value
Black (vs. white) 3.4 1.1 – 10.1 0.028
Age Category (Relative to < 50)
 50–65 0.8 0.4 – 1.9 0.698
 65+ 1.2 0.4 – 3.8 0.817
Female sex (relative to male) 0.5 0.2 – 1.5 0.223
T Stage (relative to T1)
 T2 1.0 0.4 – 2.6 0.985
 T3 2.2 0.8 – 6.3 0.131
 T4 2.4 0.9 – 6.3 0.081
Nodal disease (relative to N0) 1.2 0.5 – 3.1 0.705
Distant Metastases (relative to M0) 11.4 1.2 – 103.4 0.031
Smoking (> 10 pack-years) 0.6 0.3 – 1.4 0.221
Alcohol use (any vs. none) 1.3 0.4 – 4.0 0.672
Education (relative to less than high school)
 High school graduate 1.0 0.3 – 3.0 0.973
 Additional education past high school 0.8 0.3 – 2.1 0.600
Insurance (relative to private insurance)
 Medicaid/Medicare 4.3 1.2 – 15.9 0.028
 None 3.0 0.9 – 9.8 0.071
 Other 2.5 0.8 – 7.6 0.118
Income (relative to > 50 K)
 Income $20,000 – $50,000 0.8 0.3 – 2.2 0.683
 Income < $20,000 1.9 0.5 – 6.6 0.313
*

Model adjusted for race, age, sex, T stage, nodal disease, distant metastases, smoking, alcohol use, education, insurance status, and income